“…This is despite notable improvements in the disease screening, prevention, and treatment strategies over the past decade. CRC originating proximally (right) or distally (left) exhibits differences in embryonic origin, age-specific and sex-specific morbidity, clinical manifestation, pathological characteristics, and development ( Petrelli et al, 2017 ; Cannon and Buechler, 2019 ). At the molecular level, BRAF mutation, microsatellite instability (MSI), the CpG island methylator phenotype (CIMP)-high, or the consensus molecular subtype (CMS) CMS1 is more likely to occur in proximal CRC ( Missiaglia et al, 2014 ; Guinney et al, 2015 ; Lee et al, 2017 ), while chromosome instability, TP53 or APC mutation, or CMS2 is more likely to occur in distal CRC ( Missiaglia et al, 2014 ; Guinney et al, 2015 ; Loree et al, 2018 ).…”